This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (2)  • Contact me when this article is cited  Related Content  • Related letter  • Related article  • Similar articles in JAMA

Thomas Jefferson, MD

JAMA. 1999;281:1973-1975.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Chicago—Five diseases and the vaccines designed to protect children against them underwent scrutiny at the spring meeting of the American Academy of Pediatrics (AAP) here.

Michael A. Gerber, MD, of the National Institute of Allergy and Infectious Diseases, and Jon S. Abramson, MD, of Wake Forest University School of Medicine, presented updates on vaccines against varicella, Lyme disease, influenza, rotavirus, and group A streptococcus. The efficacy and cost-effectiveness of the first four vaccines varies greatly; the fifth is still in development.

INFLUENZA

Influenza vaccine, the oldest one of the group, is probably the most cost-effective, especially in its new form, an intranasal aerosol called cold-adapted influenza vaccine (CAIV), said Abramson. Because public health officials fear that pandemic influenza is likely to recur, it is important for physicians to have at hand a more easily administered vaccine than the current intramuscular trivalent inactivated one, he said.

. . . [Full Text of this Article]

RELATED LETTER

Lyme Disease Vaccine
David H. Schofield, Dennis Parenti, Ingrid Kohlstadt, and Thomas C. Jefferson
JAMA. 2000;283(2):199-200.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Aldicarb as a Cause of Food Poisoning—Louisiana, 1998
JAMA. 1999;281(21):1979-1980.
EXTRACT | FULL TEXT